J. Semler

发表

Alendronate Increases Bone Density and Bone Strength at the Distal Radius in Postmenopausal Women

D. Felsenberg, B. Allolio, P. Schneider, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.

M. Hahn, M. Amling, M. Priemel, 2010, Acta biomaterialia.

Paget's Disease of Bone: Histologic Analysis of 754 Patients

M. Amling, H. Minne, J. Semler, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Teriparatide in Bisphosphonate-Resistant Osteoporosis: Microarchitectural Changes and Clinical Results After 6 and 18 months

S. Majumdar, T. Link, A. Burghardt, 2011, Calcified Tissue International.

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.

Ego Seeman, Steven Boonen, Bruno Vellas, 2010, Bone.

First demonstration of the efficacy of an anti-osteoporotic treatment in very elderly osteoporotic women.

T. Spector, J. Reginster, R. Rizzoli, 2004 .

[The risk of osteoporosis].

J. Semler, 1986, Medizinische Monatsschrift fur Pharmazeuten.

Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older

S. Boonen, J. Kaufman, C. Benhamou, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone strength and density via pQCT in post-menopausal osteopenic women after 9 months resistive exercise with whole body vibration or proprioceptive exercise.

D. Felsenberg, D. Belavy, G. Armbrecht, 2013, Journal of musculoskeletal & neuronal interactions.

Trabecular Reorganization in Consecutive Iliac Crest Biopsies when Switching from Bisphosphonate to Strontium Ranelate Treatment

S. Majumdar, M. Hahn, M. Amling, 2011, PloS one.

Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis

M. Amling, M. Priemel, H. Minne, 2013, Osteoporosis International.

Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis

J. Reginster, S. Boonen, J. Kaufman, 2006 .

Clinical Aspects of Measurements of Dual Photon Absorption in Healthy Persons and Patients Suffering from Bone Mass Reduction

J. Semler, 1987 .

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.

J. Reginster, S. Boonen, J. Kaufman, 2010, Bone.